American Society of Clinical Oncology

(redirected from American Society for Clinical Oncology)

American Society of Clinical Oncology

,

ASCO

A not-for-profit professional organization of physicians who treat cancer. The group includes medical, radiological, and surgical oncologists. Website: www.asco.org
Mentioned in ?
References in periodicals archive ?
At this week's meeting of the American Society for Clinical Oncology, Slamon and scientists from the biotech firm Genentech showed how understanding these genetic miscues can pay off with a unique new therapy.
Targeted Molecular Diagnostics, LLC (TMD) announces the publication of clinical data from their Targeted Diagnostics Advocacy Program (tdap(TM)) at the 42nd annual meeting of the American Society for Clinical Oncology (ASCO) in Atlanta, GA.
Based on findings presented at the American Society for Clinical Oncology (ASCO) earlier this year, as well as additional evidence of anti-cancer activity observed since then and an encouraging side effect profile, ArQule is planning to advance ARQ 501 into Phase 2 testing within the next three to four months.
Clinical update on CA4P expected to be presented at the American Society for Clinical Oncology (ASCO) conference
This finding, together with the encouraging preliminary safety results from our Phase I clinical trial in patients with advanced malignancies presented last week at the annual meeting of the American Society for Clinical Oncology (ASCO), supports our development of the VEGF Trap as a potentially important new therapy for the treatment of diverse tumor types," commented George D.
for patients with advanced-stage non-small cell lung cancer were reported at this year's meeting of the American Society for Clinical Oncology (ASCO).
Von Hoff is a past president of the American Association for Cancer Research, a fellow of the American College of and a member and past board member of the American Society for Clinical Oncology.
The study results, which were presented at the 2002 annual meeting of the American Society for Clinical Oncology (ASCO) in Orlando, showed palonosetron was effective in the prevention of CINV during the initial 24-hour period and for several days beyond.
An update of the Phase 1 study results will also be presented at the American Society for Clinical Oncology, being held May 18-21 in Orlando, Florida.

Medical browser ?
Full browser ?